Paris manufacturer with Tampa subsidiary raises $39M in funding

  • By Laura Lyon
  • | 7:30 a.m. May 2, 2025
  • | 0 Free Articles Remaining!
Dr. Jorge Marcet and Tampa General Hospital Colorectal Surgery Team performs on the first patient in the SafeHeal SAFE-2 Clinical Study.
Dr. Jorge Marcet and Tampa General Hospital Colorectal Surgery Team performs on the first patient in the SafeHeal SAFE-2 Clinical Study.
Courtesy image
  • Tampa Bay-Lakeland
  • Share

A Paris-based firm with a U.S. subsidiary in Tampa announced Wednesday that it completed $39 million in Series C funding.

SafeHeal, a medical device company, received financing from investor Solar Eclipse, new investors Gideon Strategic Partners and M&L Healthcare, part of M&L Group and returning investors Sofinnova Partners.

Martin Sands and Steven Sands of Solar Eclipse will join as board member and observer alongside the financing. 

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • December 4, 2025
450-unit Nokomis apartment complex opens near Legacy Trail
  • December 4, 2025
Developer proposes Tampa's tallest building: 70 stories at $650 million
  • December 4, 2025
Airline adds flight from Fort Myers to upstate New York
  • December 4, 2025
50-year-old Tampa education-tech firm receives $350M investment

Sponsored Content